Chimin(SH:603222) Cai Jing Wang·2025-09-25 09:52Core Viewpoint - The company is actively addressing the legal issues surrounding the forgery case involving its former executive, while maintaining steady progress in its new drug development projects and focusing on enhancing operational management to create greater value for shareholders [1] Group 1: Legal and Operational Updates - The company has confirmed that the police have preliminarily identified the facts of the forgery case involving "He Qinghong and others," with He Qinghong being arrested by the Huangyan District Procuratorate [1] - The company assures that its new drug development projects are progressing as planned and will disclose any significant updates in accordance with regulations [1] - The management emphasizes that the company is operating normally and all business segments are developing steadily [1] Group 2: Strategic Initiatives - The company plans to leverage the innovative policies of the Boao Lecheng Pilot Zone to enhance external collaborations and increase investment in innovative drug research and development [1] - The company holds a 51% stake in Boao International Hospital, which is intended to be developed into a high-level clinical research center and translational medicine platform [1] - The management will focus on the development of existing business segments, intensify market expansion efforts, and optimize asset utilization to improve operational performance [1]